Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 689 JPY -0.53% Market Closed
Market Cap: 613.5B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note
Santen Pharmaceutical Co Ltd
/
Cash Flow Statement
/
Cash from Operating Activities

Santen Pharmaceutical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Cash from Operating Activities
¥82.2B
CAGR 3-Years
34%
CAGR 5-Years
15%
CAGR 10-Years
15%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Operating Activities
¥793.5B
CAGR 3-Years
-8%
CAGR 5-Years
14%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Operating Activities
¥532.5B
CAGR 3-Years
71%
CAGR 5-Years
24%
CAGR 10-Years
30%
Otsuka Holdings Co Ltd
TSE:4578
Cash from Operating Activities
¥302.7B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Operating Activities
¥409.9B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
27%
Astellas Pharma Inc
TSE:4503
Cash from Operating Activities
¥172.9B
CAGR 3-Years
-19%
CAGR 5-Years
-5%
CAGR 10-Years
-3%

See Also

What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
82.2B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 82.2B JPY.

What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
15%

Over the last year, the Cash from Operating Activities growth was 121%. The average annual Cash from Operating Activities growth rates for Santen Pharmaceutical Co Ltd have been 34% over the past three years , 15% over the past five years , and 15% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 198,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.